top of page


The Hardest Stage in Venture Capital Fair Value
In venture capital, there comes a point where a company has not raised a new funding round for a considerable period of time. It hasn't reached an IPO or an acquisition, there is no recent market transaction to rely on, and yet the fund still has to determine a robust fair value for its investment. This is arguably the most challenging stage in venture capital valuation. The challenge isn't performing the calculations. Modern valuation platforms can do that. The real challeng
Jul 213 min read


Evolving Venture Fair Value: From Practical Shortcuts to Structured Processes
One of the realities in venture valuation is this: Most firms don’t follow IPEV or ASC 820 in a fully “by-the-book” sense. Not because they disagree with the guidance, but because in practice, applying it rigorously can feel disproportionate to the pace and uncertainty of venture investing. So, what happens instead? Fair value often leans on practical, straightforward approaches: • Recent transaction prices • Waterfall-based allocations • Selective updates between financing e
Jun 242 min read


📅 IPEV Board statement: applying the 2025 Guidelines in today’s market environment
As we approach the end of Q2 2026, private markets continue to navigate heightened uncertainty—from geopolitical developments to shifts in growth expectations, the impact of AI, and increased scrutiny in private credit. In this context, robust and disciplined fair value measurement has never been more important. It is central not only to compliance, but also to how investors, boards, and stakeholders interpret risk, report performance, and make capital allocation decisions.
Jun 131 min read


Most Firms Don’t Follow IPEV. Most Still Sign That They Do!
It’s Easier Than Ever to Actually Be. 📝 Every year, firms sign financial statements referencing IPEV / ASC 820. Most realize they may not be fully aligned with the modern standard, and have simply continued using the familiar approach the industry has relied on for years. 🤝 Side letters smooth things over. Audit notes get tucked away. The disclosures look routine. And the signatures go on. But it’s worth asking, honestly: 🔍 You know you’re not fully IPEV / ASC 820 complian
Apr 281 min read


🔍 Rethinking Fair Value in Venture Capital - What IPEV, AICPA, and ASC 820 Really Mean for Today’s VC Firms
🔑 Key Takeaways • VC valuations require a different mindset than PE. Early stage companies behave like options, not steady state businesses. • OPM, PWERM, and (rarely) CVM are the right tools for capturing uncertainty, optionality, probability, and complex capital structures. • Fair value and investment analysis share the same foundations. The same models used for ASC 820 compliance — OPM, PWERM, breakpoints, and probability based waterfalls — are also the backbone of due
Apr 144 min read
If you missed my recent post on fair value for venture-backed companies, here are five essentials you should know about the three core IPEV (ASC 820) valuation methodologies
1️⃣ There are three core methodologies venture valuations rely on Under IPEV and ASC 820, three frameworks dominate fair value analysis for VC-backed companies: PWERM, OPM, and CVM. Each approaches the valuation problem from a different angle and is suited to different circumstances. 2️⃣ PWERM models real exit scenarios The Probability-Weighted Expected Return Method (PWERM) values a company by modeling discrete outcomes, even incorporating future anticipated funding rounds,
Mar 51 min read
bottom of page
